INR 800.95
(-4.21%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 6.67 Billion INR | -61.53% |
2022 | 17.33 Billion INR | 41.91% |
2021 | 12.21 Billion INR | 581.91% |
2020 | 1.79 Billion INR | 107840.96% |
2019 | 1.66 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 4.37 Billion INR | 4.06% |
2024 Q1 | 1.66 Billion INR | -9.22% |
2023 Q2 | 4.22 Billion INR | -2.77% |
2023 FY | 6.67 Billion INR | -61.53% |
2023 Q4 | 1.83 Billion INR | -52.95% |
2023 Q3 | 3.9 Billion INR | -7.48% |
2023 Q1 | 4.34 Billion INR | 6.03% |
2022 Q2 | 4.62 Billion INR | 4.93% |
2022 Q1 | 4.4 Billion INR | 83.73% |
2022 FY | 17.33 Billion INR | 41.91% |
2022 Q4 | 4.09 Billion INR | -2.86% |
2022 Q3 | 4.21 Billion INR | -8.86% |
2021 FY | 12.21 Billion INR | 581.91% |
2021 Q4 | 2.39 Billion INR | -34.49% |
2021 Q3 | 3.66 Billion INR | 10.92% |
2021 Q2 | 3.3 Billion INR | 6.78% |
2021 Q1 | 3.09 Billion INR | 72.55% |
2020 Q4 | 1.79 Billion INR | -20.11% |
2020 Q3 | 2.24 Billion INR | 169.8% |
2020 Q2 | -3.21 Billion INR | 0.0% |
2020 FY | 1.79 Billion INR | 107840.96% |
2019 FY | 1.66 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Biocon Limited | 40.9 Billion INR | 83.693% |
Blue Jet Healthcare Limited | 531.85 Million INR | -1154.113% |
Concord Biotech Limited | 1.45 Billion INR | -356.942% |
Dishman Carbogen Amcis Limited | 5.14 Billion INR | -29.58% |
Lyka Labs Limited | 599.4 Million INR | -1012.766% |
Panacea Biotec Limited | 1.99 Billion INR | -234.269% |
Piramal Pharma Limited | 19.91 Billion INR | 66.506% |
SMS Lifesciences India Limited | 602.96 Million INR | -1006.197% |
Supriya Lifescience Limited | 1.08 Billion INR | -517.507% |
Syngene International Limited | 5.99 Billion INR | -11.259% |
TAKE Solutions Limited | 396.91 Million INR | -1580.482% |
Zota Health Care Limited | 457.83 Million INR | -1356.857% |